UNICHEMLAB
Unichem Laboratories Limited
Each stock's 10,000-path forecast, rendered as light.
Unichem Laboratories Limited (UNICHEMLAB) Stock Analysis & Case Study
Is UNICHEMLAB a good buy? The data-driven verdict.
Unichem Laboratories Limited (UNICHEMLAB) trades at ₹490,on the numbers it tread carefully, a Downstox Snapshot Score of 33/100.
On the numbers, Unichem Laboratories Limited (UNICHEMLAB) tread carefully, a Downstox Snapshot Score of 33/100, weighing expensive at 42.1× earnings, ROE of 3.2%, a 51% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
UNICHEMLAB fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How UNICHEMLAB ranks against the 2,373 companies in our screener
- UNICHEMLAB's market cap of 3,448 Cr ranks in the 60th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- UNICHEMLAB's book value of ₹386 ranks in the 86th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- UNICHEMLAB's promoter holding of 70.2% ranks in the 75th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- UNICHEMLAB's 3-year profit (PAT) growth of 35.0% ranks in the 74th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- UNICHEMLAB's 3-year revenue growth of 18.0% ranks in the 69th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- UNICHEMLAB's debt-to-equity ratio of 0.18x is lower than 65% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is UNICHEMLAB overvalued? UNICHEMLAB P/E vs peers
UNICHEMLAB trades at 42.1× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
UNICHEMLAB share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of UNICHEMLAB history (6%/yr drift, 44%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| UNICHEMLAB 2027 | ₹281 | ₹497 | ₹880 | +2% |
| UNICHEMLAB 2028 | ₹229 | ₹505 | ₹1,114 | +3% |
| UNICHEMLAB 2029 | ₹196 | ₹513 | ₹1,340 | +5% |
| UNICHEMLAB 2030 | ₹168 | ₹520 | ₹1,609 | +6% |
| UNICHEMLAB 2031 | ₹153 | ₹528 | ₹1,826 | +8% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability UNICHEMLAB goes up, or doubles?
The bull case for UNICHEMLAB
- Low price-to-book of 1.27×, the market is paying little over the company's net assets.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹1,340.
The bear case & risks
- UNICHEMLAB's P/E of 42.1x is lower than 32% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- UNICHEMLAB's return on equity of 3.2% ranks in the 23rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹196.
UNICHEMLAB volatility & expected range, how bumpy is the ride?
Over the last 9.8 years UNICHEMLAB compounded at 6%/year with annualized volatility of 44%. That volatility implies a 1-year 80% range of ₹281-₹880, the honest backbone behind any single price target.
UNICHEMLAB price forecast, the full 60-month probability fan
UNICHEMLAB price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds UNICHEMLAB hits common targets within the simulated horizon?
Full multi-horizon detail on the UNICHEMLAB price target & forecast page.
UNICHEMLAB Piotroski F-Score: 5/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. UNICHEMLAB scores 5/8, mixed financial health.
UNICHEMLAB MTF margin & leverage across 10 brokers
Margin Trading Facility lets you buy UNICHEMLAB with part of the capital. Lower margin % = higher leverage. Rates compared across 10 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 37.78% | 2.6× |
| Zerodha | 50.00% | 2.0× |
| Groww | 60.00% | 1.7× |
| Dhan | 40.00% | 2.5× |
| Kotak Neo | 100.00% | 1.0× |
| Paytm Money | 38.11% | 2.6× |
| Pocketful | 50.00% | 2.0× |
| Anand RathiCHEAPEST | 37.74% | 2.6× |
| Bajaj Broking | 39.00% | 2.6× |
| Share India | 37.94% | 2.6× |
Compare every broker on the UNICHEMLAB MTF page.
About Unichem Laboratories Limited: sector, index & market-cap context
Unichem Laboratories Limited (UNICHEMLAB) is a small-cap NSE-listed company, with a market capitalisation of ₹3,448 Cr. See more stocks on our screener.
How the UNICHEMLAB Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Unichem Laboratories Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
UNICHEMLAB analysis, FAQs
Is Unichem Laboratories Limited (UNICHEMLAB) a good buy?
On the numbers, Unichem Laboratories Limited (UNICHEMLAB) tread carefully, a Downstox Snapshot Score of 33/100, weighing expensive at 42.1× earnings, ROE of 3.2%, a 51% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is UNICHEMLAB overvalued or undervalued?
UNICHEMLAB trades at 42.1× earnings, expensive versus the ~22× long-run Nifty average.
What is the UNICHEMLAB share price target for 2031?
UNICHEMLAB's probability-weighted 2031 median target is ₹528, with an 80% range of ₹153-₹1,826 (10,000-path Monte-Carlo).
What is the probability UNICHEMLAB doubles in 5 years?
The modelled probability of UNICHEMLAB reaching ₹980 (2×) within 5 years is 26%.
What is the bull case for UNICHEMLAB?
Low price-to-book of 1.27×, the market is paying little over the company's net assets.
What are the risks in UNICHEMLAB?
UNICHEMLAB's P/E of 42.1x is lower than 32% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. UNICHEMLAB's return on equity of 3.2% ranks in the 23rd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.